I agree to be bound by the terms of this notice. These two key additions to the executive team of ADVANZ PHARMA are accompanied by several other senior leadership changes. ADVANZ PHARMA has established a Compliance Committee and the committee meets on a quarterly basis. Cookie Policy. This is bolstered by an established brands business unit of more than 180 molecules sold into 100 countries across a wide range of therapy areas such as CVD, pain management, ophthalmology, urology, and central nervous system disorders. With an agile and experienced team, including direct sales, marketing, and medical capability across many of Europe's major markets, ADVANZ PHARMA supplies, innovates and enhances the critical medicines patients depend on, ensuring continued patient access and improving healthcare outcomes. I certify that I am not (nor do I act on behalf of someone who is) resident in any country that renders the accessing of this area of the website or parts thereof illegal. He led businesses such as large European-based multinational Pharmaco, US-based Biotech, and Private Equity portfolio companies and likes to work with strong teams to drive business growth, transformation, and M&A. Dr Steffen Wagner is to become the new Chief Executive Officer of ADVANZ PHARMA, starting early 2022. ADVANZ PHARMA is a global pharmaceutical company with a strategic focus on specialty and hospital pharmaceuticals. As a consequence of legal restrictions, the release, publication or distribution of information contained in this area of the website in certain jurisdictions or to certain persons may be restricted or unlawful. Javier has deep and diverse experience across multiple therapeutic areas in both innovative and mature products. Most recently, he has been CFO of Merck Healthcare, part of Merck KGaA, where he also served as Global Head of M&A and Business Development, driving major strategic acquisitions. Box 1674, 1201 Geneva, Switzerland Andreas Stickler will join as the Company's new Chief Financial Officer in January 2022. strategic leadership and to create robust accountability, oversight and assurance for educational and financial performance of the school. This includes cookies for access to secure areas and CSRF security. Raj holds degrees in medicine and surgery from Imperial College, London as well as being Fellow of the Royal College of Surgeons and an MBA from London Business School. Dr. Steffen Wagner appointed as new Chief Executive Officer and Andreas Stickler as new Chief Financial Officer. He succeeds Graeme Duncan, who will step down from his role and become a special advisor to. Our values reflect who we are and what we stand for. These senior leadership changes build upon ADVANZ PHARMA's successful 2021 and will help fuel the Company's next phase of growth. Dr Steffen Wagner is to become the new Chief Executive Officer of ADVANZ PHARMA, starting early 2022. Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements as a prediction of actual results. In particular, the information contained in this area of this website does not constitute an offer to sell or otherwise dispose of or any invitation or solicitation of any offer to purchase or subscribe for any securities in any jurisdiction in which such offer or solicitation is unlawful. He was in leadership roles in major international pharmaceutical companies, is a proven industry leader and, in his short time as a Director, has demonstrated a clear understanding of the Company's current situation and its opportunities. Craft's default cookies do not collect IP addresses. As a company, we are proud to say we are small enough to care but big enough to make a difference. The Compliance Officer works with relevant resources to evaluate audit findings and ensure the implementation of any corrective action. The information contained in this area of this website is being made available in good faith and for information purposes only in compliance with the City Code on Takeovers and Mergers and is subject to the terms and conditions set out below. These senior leadership changes build upon ADVANZ PHARMA's successful 2021 and will help fuel the Company's next phase of growth. Dr. Steffen Wagner appointed as new Chief Executive Officer and Andreas Stickler as new Chief Financial Officer. He succeeds Graeme Duncan, who will step down from his role and become a special advisor to the Board. ADVANZ PHARMAs corrective and preventative actions may include: revising the compliance program, policies, and/or procedures; revising the role of the Compliance Committee; increased auditing and monitoring; revising the training program. In January 2022, Chris Britten will join Susanna El-Armale's team as Senior Vice President for M&A, following his role as Head, M&A for Neuraxpharm. London, April 1, 2022: In accordance with previous announced information, ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA"), a pharmaceutical company with a strategic focus on specialty pharmaceuticals and specialty & hospital generics in Europe, today welcomes Steffen Wagner as its new CEO. "ADVANZ PHARMA is building a leadership position in Europe as a specialty pharmaceutical company and they are an ideal commercialization partner for Allecra as we advance toward regulatory submission for cefepime/enmetazobactam," stated Andreas Kranzusch, Chief Financial Officer at Allecra Therapeutics. Fiona Huzarski has worked for over 20 years as a senior HR professional, 15 years within the Pharmaceuticals industry. Our Australasian office is based in Sydney, Australia. Steffen is a medical doctor by training, has previously held senior roles with Biogen and within the Novartis Group, and worked as a consultant at McKinsey & Company and Bain & Company. To find out more, please visit our website: https://www.advanzpharma.com. Eve has broad legal experience in international life sciences and held roles at Hikma Pharmaceuticals, Pharmascience and IQVIA (formerly IMS Health) where she worked in the R&D, Scientific Affairs, Business Development, M&A, Global Operations, Supply Chain, Commercial, Marketing and Sales teams. Before venturing into life sciences, Eve also worked for law firms in Paris and Montreal. Paris & North France (1/2 France) Therapeutic Areas: Infectiology, Oncology / Gastroenterology & Neuroendocrinology (Rare diseases) Rare Diseases: Lanreotide in acromegaly and neuroendocrine tumours (prelaunch and launch) Infectiology: dalbavancine in skin infection & ceftobirole in hospital and . Rainer joined from Goldman Sachs where he was Managing Director focusing on European healthcare companies. The documents included in this area of the website speak only at the specified date of the relevant document and neither ADVANZ nor any of its affiliated companies has or accepts any responsibility or duty to update such documents (other than to the extent such duty arises as a matter of law). ADVANZ PHARMA. These forward looking statements are not guarantees of future performance. The documents included in this area of the website speak only at the specified date of the relevant document and neither ADVANZ nor any of its affiliated companies has or accepts any responsibility or duty to update such documents (other than to the extent such duty arises as a matter of law). None of the Responsible Persons, ADVANZ or its affiliated companies have reviewed and none of them is responsible for, or accepts any liability in respect of, any information on any other website that may be linked to this website by a third party. On October 11, Anke Niedernberg joined as Senior Vice President and Head of the Transformation Office. If you are in any doubt, you should not continue to seek to access this area of the website. Prior to joining, Rajs healthcare experience spans both working as a practitioner, having initially qualified and practiced as a cardiac surgeon at Oxford, through to extensive transactional experience gained as Co-Head of Goldman Sachs healthcare investment banking practice where he advised private equity and corporate clients. If you do not click I AGREE below you will not be permitted access to this area of the website. Raj has over 25 years of experience in the healthcare industry. His predecessor, Graeme Duncan, has been with ADVANZ PHARMA since 2014 and has played a significant role in building the Company to date. We continue to work closely with our partners to enhance our medicines and add value through innovation, particularly in the anti-infectives space which has had limited investment in recent years, despite the ever-increasing health burden of antimicrobial resistance. Susanna brings broad experience spanning both M&A and BD activities and will be a central driver of the Company's active corporate development agenda. Previously he worked at Human Genome Sciences, Vertex, and Biogen. THIS NOTICE REQUIRES YOU TO CONFIRM CERTAIN MATTERS (INCLUDING THAT YOU ARE NOT RESIDENT IN SUCH A JURISDICTION), BEFORE YOU MAY OBTAIN ACCESS TO THE INFORMATION IN THIS AREA OF THE WEBSITE. His predecessor, Adeel Ahmad, has been with the Company since 2013 and has helped deliver major transformation projects and built a sustainable business from which to grow. Steffen Wagner. As Chief Operations Officer for ADVANZ PHARMA, Karl leads all operations functions globally, including scientific affairs (medical, regulatory and quality), supply (supply chain and supplier alliance management), new product introductions and technical operations. Electronic versions of these materials are not directed at or accessible by persons resident in any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction. He brings a wealth of global finance, healthcare and M&A expertise to the team. If you do not click I AGREE below you will not be permitted access to this area of the website. Dr. Steffen Wagner appointed as new Chief Executive Officer and Andreas Stickler as new Chief Financial Officer LONDON, Nov. 18, 2021 /PRNewswire/ - ADVANZ. He brings extensive international pharma experience that will be highly valuable in supporting ADVANZ PHARMA's continued journey. Simon has had over 20 years experience within the ADVANZ family of companies and has focused the majority of his career Internationally being responsible for both direct and indirect business across Europe, North America, MENA, Latin America and Asia whilst living and working in the USA, UK and Jersey. Most recently, he has been CFO of Merck Healthcare, part of Merck KGaA, where he also served as Global Head of M&A and Business Development, driving major strategic acquisitions. Steffen joined ADVANZ PHARMA as CEO in April 2022 and has broad general management experience in international life science businesses. ADVANZ PHARMA policies and procedures were developed to ensure that interactions with healthcare professionals are appropriate, ethical, and consistent with applicable laws and standards. About ADVANZ PHARMAADVANZ PHARMA is headquartered in London and has commercial affiliates in Europe, North America and Australia, and supply chain, regulatory and administrative operations in India. These factors include, but are not limited to, changes in economic conditions, changes in the level of capital investment, success of business and operating initiatives and restructuring objectives, costs associated with research and development, changes in the prospects for products in the research and development pipeline of ADVANZ, customers strategies and stability, changes in the regulatory environment, fluctuations of interest and exchange rates, the outcome of litigation, government actions and natural phenomena such as floods, earthquakes and hurricanes. ADVANZ PHARMA has an operational headquarters in London, an operations centre of excellence in Mumbai, offices in Geneva and Paris and commercial affiliates in North America, Europe and Australia/NZ, together with an established global network of commercial partners throughout the rest of the world Cookies that the site cannot function properly without. I was employed to assist the laboratory team, which included: preparation of stock solutions - reagents and sample preparation for testing, along with laboratory maintenance including calibration of equipment and lab ordering. THESE MATERIALS ARE NOT DIRECTED AT OR TO BE ACCESSED BY PERSONS RESIDENT IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION OR WOULD RESULT IN A REQUIREMENT TO COMPLY WITH ANY CONSENT OR OTHER FORMALITY WHICH ADVANZ PHARMA CORP. LIMITED REGARDS AS UNDULY ONEROUS. I certify that I am not (nor do I act on behalf of someone who is) resident in any country that renders the accessing of this area of the website or parts thereof illegal. He will continue working with the Board as a special advisor. Steffen is a medical doctor by training, has previously held senior roles with Biogen and within the Novartis Group, and worked as a consultant at McKinsey & Company and Bain & Company. As ADVANZ PHARMA evolves as a company and as regulations change, it may amend its compliance program. In total, we have over 100 employees here. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. In 2021, the Company delivered continued strong financial performance, succeeded in acquiring additional strategic assets, commenced the European launch of a generic version of Lanreotide and bolstered its organic . Head of Business Development at Advanz Pharma Hamburg und Umgebung. Andreas Sticklerjoined ADVANZ PHARMA from Merck Healthcare, part of Merck KGaA, where he was Chief Financial Officer and also served as Global Head of M&A and Business Development for many years. In January 2022, Chris Britten will join Susanna El-Armale's team as Senior Vice President for M&A, following his role as Head, M&A for Neuraxpharm. Its where we serve Australia, New Zealand and the Pacific Island countries from. I agree to be bound by the terms of this notice. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. Advanz Pharma is a Private Equity portfolio company of Nordic Capital. These statements are based on the current expectations of the management of ADVANZ and are naturally subject to uncertainty and changes in circumstances. This area of the website contains forward-looking statements. INFORMATION REGARDING FORMAL SALE PROCESS. our focus on complex medicines means building a portfolio of hospital specific products and enhanced commercial and medical capabilities, in key therapeutic areas such as anti-infectives and endocrinology that bring innovation to improve patient access and health outcomes while our established products business with its portfolio of more than 180 Dr Steffen Wagner is currently a member of the executive management team at STADA Arzneimittel AG and has been responsible for the company's European Markets division. You are attempting to enter the area of this website that is designated for the publication of documents and information in connection with ADVANZ PHARMA Corp. Limited (ADVANZ) formal sale process. You should not forward, transmit or show the announcements, information or documents contained in this area of the website to any person. Graeme Duncan, ADVANZ PHARMA CEO, on what #BeyondFulfilment encapsulates. In 2021, the Company delivered continued strong financial performance, succeeded in acquiring additional strategic assets, commenced the European launch of a generic version of Lanreotide and bolstered its organic pipeline with further in-licensing deals. Creating, deleting User accounts. He brings extensive international pharma experience that will be highly valuable in supporting ADVANZ PHARMA's continued journey. Apr 2018 - Jun 20202 years 3 months. Manager - M&A/BD&L. Ipsen. ADVANZ PHARMA has established and implemented a Code of Conduct (the Code), which sets forth ADVANZ PHARMA's commitment to ethical business conduct. Dr Steffen Wagner is to become the new Chief Executive Officer of ADVANZ PHARMA, starting early 2022. The Compliance Committee reviews and approves all suggested changes. The company focuses on a number of therapy areas including endocrinology, ophthalmology, urology, anti-infectives, pain management, central nervous system disorders, oncology, haematology, cardiology and intensive care medicine. Dati relativi al dispositivo e alla connessione a Internet, come l'indirizzo IP, Attivit di navigazione e di ricerca durante l'utilizzo dei siti web e delle app di Yahoo. In 2018, a year after the CMA first accused the company of abusing its position, Concordia changed its name to Advanz Pharma. To serve the needs of patients and healthcare providers across the world by operating at high ethical standards. Noi, di Yahoo, facciamo parte della famiglia di brand di Yahoo. MISSISSAUGA, ON, July 25, 2019 /CNW/ - ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), a global pharmaceutical company focused on serving the needs of patients and healthcare providers around the world with enhanced access to high quality, niche-established medicines, today commented on the issuance by the UK Competition and Markets Authority (the "CMA") of a Statement of . About ADVANZ PHARMAADVANZ PHARMA is headquartered in London and has commercial affiliates in Europe, North America and Australia, and supply chain, regulatory and administrative operations in India. On October 11, Anke Niedernberg joined as Senior Vice President and Head of the Transformation Office. PINNACLE BIOLOGIS Global Headquarters 2801 Lakeside Drive Suite 210 Bannockburn, IL 60015 Direct: +1 847 283 7690. info@pinnaclebiologics.com. Dr. Steffen Wagner appointed as new Chief Executive Officer and Andreas Stickler as new Chief Financial Officer. We need to rebuild shareholder value and believe adding Allan to our already strong executive leadership . With an agile and experienced team, including direct sales, marketing, and medical capability across many of Europe's major markets, ADVANZ PHARMA supplies, innovates and enhances the critical medicines patients depend on, ensuring continued patient access and improving healthcare outcomes. He succeeds Graeme Duncan, who will step down from his role and become a special advisor to the Board. If it is determined that noncompliant conduct has occurred, appropriate parties are responsible for corrective and/or disciplinary actions. Andreas Stickler will join from Merck Healthcare as the new Chief Financial Officer, succeeding Adeel Ahmad. Andreas Stickler will join as the Company's new Chief Financial Officer in January 2022. LONDON, Nov. 18, 2021 /CNW/ - ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company"), a specialty pharmaceutical company with a strategic focus on complex medicines in Europe, today announced several changes in senior leadership roles as it enters the next phase of its growth journey. He is a medical doctor by training, has previously held senior roles with STADA, Biogen and within the Novartis Group, and worked as a consultant at McKinsey and Bain. The Hotline is available 24 hours a day/7 days a week to allow confidential and anonymous reporting. Help people lead better lives with medicines, that without our focus, may not be available. THE DOCUMENTS IN THIS AREA OF THE WEBSITE MAY NOT BE DOWNLOADED, FORWARDED, TRANSMITTED OR SHARED WITH ANY OTHER PERSON EITHER IN WHOLE OR IN PART WHERE TO DO SO WOULD OR MAY CONSTITUTE A BREACH OF ANY APPLICABLE LOCAL LAWS OR REGULATIONS. Careers & Culture She brings a broad skillset to the leadership team, having spent time in private equity, consulting and running major change and growth projects for Sandoz for the last ten years. Customer Service Leadership Alle Kurse anzeigen Cerem avdars ffentliches Profil-Badge Dieses LinkedIn Profil auf anderen Websites verwenden . Prior to joining ADVANZ PHARMA as Vice President of Global HR in August 2019, she was Global HR Director at Britannia Pharmaceuticals, part of the STADA group. Javier holds bachelors degree in law and has complemented his education with an Executive MBA at the Instituto de Empresa Business School. Nick joined ADVANZ PHARMA as Chief Medical Officer in June 2020. Switzerland ADVANZ PHARMA, Place des Alpes 2-4, P.O. He succeeds Graeme Duncan, who will step down from his role and become a special advisor to the Board. Javier has over 30 years experience within the pharmaceutical industry spending time in both big pharma and within the biotech space. In particular, you should not forward or transmit the announcements, information or documents contained in this area of the website to any jurisdiction where it would be unlawful to do so. About ADVANZ PHARMAADVANZ PHARMA is headquartered in London and has commercial affiliates in Europe, North America and Australia, and supply chain, regulatory and administrative operations in India. To find out more, please visit our website: https://www.advanzpharma.com. If you would like to view this area of the website, please read this notice carefully. ADVANZ PHARMA CORP. LIMITED: attualit, news e informazioni azione ADVANZ PHARMA CORP. LIMITED | 80CD | CA20653P1027 | Deutsche Boerse AG Cookie Policy. Copyright 2022 Advanz Pharmaceutical Investors. If you are in any doubt about the contents of this area of the website or the action you should take, you should seek your own financial advice from an independent financial adviser authorised under the Financial Services and Markets Act 2000 or, if you are located outside the United Kingdom, from an appropriately authorised independent financial adviser. Dr Nick Warwick has over 30 years of experience both in the pharmaceutical industry and as a medical doctor. ADVANZ PHARMAs disciplinary actions may include the following: termination; disciplining any involved employee(s); disciplining supervisor for failure to monitor employees appropriately. This notice applies to all persons who view this area of the website and, depending on where you are located, may affect your rights or responsibilities. MISSISSAUGA, ON, May 23, 2019 /CNW/ - ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), a global pharmaceutical company focused on serving the needs of patients and healthcare providers around the world with enhanced access to high quality, niche-established medicines, today commented on the issuance by the UK Competition and Markets Authority (the "CMA") of a Statement of . Prior to joining ADVANZ PHARMA, Anke worked at McKinsey, HgCapital and most recently, held various global roles across Strategy, Launch and Portfolio Management as well building and driving the local German ehealth Strategy at Sandoz. Forward-looking statements include, without limitation, statements typically containing words such as intend, expect, anticipate, target, estimate, plan, strategy, will, should, may, goal, seek, believe, predict, continue, future, could, can and words of similar import. Health Protection Agency. You are attempting to enter the area of this website that is designated for the publication of documents and information in connection with ADVANZ PHARMA Corp. Limited (ADVANZ) formal sale process. This notice shall be governed by, and interpreted in accordance with, English law. ADVANZ PHARMA has a broad expertise in several therapeutic areas with strengths in the critical care, anti-infectives, endocrinology, cardiovascular and central nervous system therapeutic areas, along with direct sales access in Europe, making it an attractive partner when commercialising complex medicines, especially in the hospital channel. These senior leadership changes build upon ADVANZ PHARMA's successful 2021 and will help fuel the Company's next phase of growth. If you are in any doubt about the contents of this area of the website or the action you should take, you should seek your own financial advice from an independent financial adviser authorised under the Financial Services and Markets Act 2000 or, if you are located outside the United Kingdom, from an appropriately authorised independent financial adviser.